Trademark: 97542596
Word
OTRUSVYQUE
Status
Pending
Status Code
686
Status Date
Tuesday, April 2, 2024
Serial Number
97542596
Mark Type
4000
Filing Date
Wednesday, August 10, 2022
Published for Opposition
Tuesday, April 2, 2024

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 2, 2024
Published For Opposition
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Feb 23, 2024
Approved For Pub - Principal Register
Feb 23, 2024
Teas/Email Correspondence Entered
Feb 23, 2024
Correspondence Received In Law Office
Jan 10, 2024
Suspension Checked - To Attorney For Action
Sep 27, 2023
Teas Response To Suspension Inquiry Received
Jul 12, 2023
Teas Change Of Correspondence Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Owner Address Received
May 30, 2023
Notification Of Letter Of Suspension E-Mailed
May 30, 2023
Letter Of Suspension E-Mailed
May 30, 2023
Suspension Letter Written
May 26, 2023
Assigned To Examiner
Aug 30, 2022
New Application Office Supplied Data Entered
Aug 13, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24